Table 2.

Univariate logistic regression analyses of DCM and ICM patients

Variables	DCM			ICM
	OR	95% CI	P value	OR	95% CI	P value
Age	1	0.96–1.03	.962	1.03	0.97–1.1	.294
Male	0.81	0.31–2.1	.66	1.07	0.33–3.45	.914
Hypertension	0.77	0.32–1.82	.546	0.44	0.13–1.47	.182
DM	1.07	0.39–2.94	.894	0.17	0.05–0.62	.007
QRS duration	1.02	1.0–1.05	.014	1.03	1.0–1.07	.044
NT-proBNP	0.02	0.0–0.61	.026	0.15	0.0–9.53	.371
NS-VT	0.25	0.1–0.64	.004	0.28	0.08–0.94	.039
NYHA
II			.037			.191
III	1.68	0.34–8.35	.526	2.14	0.41–11.16	.366
IV	0.504	0.108–2.361	.385	0.66	0.13–3.47	.630
LVEF by echo	0.97	0.92–1.04	.404	1.02	0.94–1.09	.678
LVEDV	1	1.0–1.0	.438	0.99	0.98–1.0	.009
LVESV	1	1.0–1.0	.422	0.99	0.98–1.0	.009
Scar burden	0.96	0.93–1.0	.029	0.97	0.93–1.0	.075
Systolic PSD	0.98	0.96–1.0	.017	0.98	0.95–1.0	.064
Systolic PBW	0.99	0.99–1.0	.009	1	0.99–1.0	.107
Diastolic PSD	0.97	0.95–0.99	.003	0.97	0.95–1.0	.056
Diastolic PBW	0.99	0.99–1.0	.003	1	0.99–1.0	.171
LVMD concordance
Both match			.000			.364
One match	127.50	10.48–1551.48	.000	5.00	0.45–55.63	.190
Neither match	11.93	2.49–57.28	.002	3.00	0.27–33.49	.372
LV lead in scarred myocardium	2.99	1.09–8.18	.033	3.9	0.38–40.37	.254

ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blocker; CAD, coronary artery disease; MI, myocardial infarction; EDE, end-diastolic eccentricity; ESE, end-systolic eccentricity; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; EDVi, end-diastolic volume index; ESVi, end-systolic volume index; PSD, phase standard deviation; PBW, phase bandwidth